Abbreviations

Objectives
The main objectives of premarital counseling have been summarized in the following box:
Box 1: Main Objectives of Premarital Counseling Services
1. To reduce the incidence of common haemoglobinopathies in Iraq, e.g. thalassemias and sickle cell anemia. 2. To reduce other hereditary disorders by identifying problems followed by counseling. 3. Counseling regarding high-risk behaviors, including those related to HIV, Hepatitis B, and other infectious diseases. 4. Early detection and treatment of some sexually transmitted diseases. 5. To promote awareness regarding reproductive health, family planning, and healthy lifestyles. 6. To provide couples with medical, social, and psychological support. 7. To provide immunizations as required.
Counseling should be provided to the couples together, unless a specific problem requires personal confrontation. Couples should understand that counseling does not guarantee the absence of congenital anomalies, nor does it assess their fertility. The certificate on premarital counseling risk assessment form will be issued only after counseling both partners together, stating that "couples were counseled together, and the decision of marriage is left to couples themselves". The certificate will be registered, and given a registration number and duly signed and stamped by the examining physician and the director of health facility. The following pages are the guidelines for all care givers to help them in dealing with couples who want to marry. They assist in detecting the majority of common haemoglobinopathies and sexually transmitted diseases in each partner. They provide also certain clues to determine the possibility of transmission of inherited diseases to offspring.
Chapter 2: Plan of Action in Premarital Counseling Premarital Counseling Risk Assessment Form
The assessment form in premarital examination (Annex 1) should include the following: 1. Administrative information: name of health institution, sequential number of form, number of certificate and its date of issue. . Socio-demographic data: name, age, and occupation, of partners; in addition to the degree of consanguinity between them. 3. Family history: inherited blood diseases (thalassemia, sickle cell anemia, and hemophilia), mental disability, and congenital physical handicap. Any important notes should be recorded. 4. Laboratory investigations: blood grouping and Rh factor, RBC indices (MCV and MCH), VDRL, HBsAg, and tests for HIV and tuberculosis. 5. Procedures: the female partner should be given a dose of tetanus toxoid after checking her immunization status. The field concerning this action is labeled. 6. Signatures of couple, names and signature of examining doctor and director, and stamp of health institution.
Premarital Counseling Clinical Pathway
 Every couple who want to get married should be subjected to Premarital Counseling.  Premarital Counseling is provided by physicians with the help of trained paramedic or other health care provider.  Couples are referred to health center within the catchment area (one of the health centers they belong to) for getting the service of premarital counseling.  Appointments are arranged by the relevant clerk or health care provider  Usually Premarital Counseling is completed in 2-3 visits in normal situation.
I. The First Visit (to the Paramedics/HCP) 1 . Basic data and address on the PC Risk Assessment Form is filled in, either by the HCP or the client. 2. The degree of consanguinity between the couple must be identified. 3. HCP should take family history as per the PC Risk Assessment Form 4. When applicable, check the weight and height and calculate the body mass index (BMI). 5. Request blood sample from both partners for required lab investigations and record the results when coming back. . The female partner should be given a dose of tetanus toxoid, after checking history of tetanus vaccination, and the field concerning this action on the Premarital Counseling Form is labeled. . Premarital educational booklet will be given to each client. The booklet includes information on the following:  The concept and aim of Premarital Counseling  Common haemoglobinopathies in Iraq  Sexually transmitted diseases (STI)
 Healthy life-style  Concept of family planning and methods of contraception.  Breast self-examination, the maneuver and frequency . Each partner should sign the premarital counseling consent. . The phone number and any possible way for contact with the partners should be requested.
. Each client should be given an appointment for counseling before they leave. 
II. Preparation for the next visit
IV. Documentation
 In order to avoid the loss of lab tests and make benefit from them in the future, it is advised to undertake the following:  A copy from the Risk Assessment Forms will be kept in a Box File till the couple opens a family folder in a health center, and then it will be transferred to their HC and kept in their Family Folder.  personal card; or even a copy of Risk Assessment Forum, is given to each client with his/her laboratory results  Partner with abnormal finding/s or result/s, which needs further assessment, evaluation, management and counseling will be offered treatment locally or referred to secondary care.  Extra appointment/s can be arranged if necessary.  Couples found to have a risk of an affected offspring will be referred for genetic counseling at the secondary care.  Both partners should be advised to share data by themselves.  If they agree, an appointment is booked for counseling both partners together.  In the cases required referral to secondary care, issue the Premarital Counseling Certificate based on a written feedback from the secondary care.  When there is a documented reproductive genetic risks from this marriage, it is advised that the doctor to write "from medical aspect, this marriage may lead to the following disease in the next generation:" 
II. Couples Who May Be at Risk
One partner has sickle cell trait or B-thal trait and the other partner has hypochromia microcytosis and/or HBA2 between 3.4-.
Note:
If you are sure of the diagnosis, no need to refer the couples when both partners are having alpha-thalassemia gene.
Chapter 3: Premarital Guidelines for Most Common Heamoglobinopathies in Iraq Overview
With approximately 7% of the worldwide population being carriers, hemoglobinopathies are the most common monogenic diseases and one of the world's major health problems. They were originally found mainly in the Mediterranean area and large parts of Asia and Africa. International migration has spread them from those areas all over the world. In many parts of world today, hemoglobin (Hb) defects are classified as endemic diseases. Iraq is one of the countries which are endemic with different types of heamoglobinopathies.
There are several epidemiological studies on their frequency. The prevalence of gene carriers is high giving a figure of millions among the entire population. The total number of patients diagnosed with these diseases in the MoH laboratories during the last years is tens of thousands. Thus, detection and advice about these disease becomes the corner stone element in Premarital Counseling in order reduce the burden of this problem.
Types and Composition of Adult Hemoglobin
Normal hemoglobin (Hb) in adults is composed of the following:
1. Hb A: this is composed of two alpha and two beta chains, it constitute 95% of total hemoglobin. . Hb A2: this is composed of two alpha and two delta chains, it constitute 3% of total hemoglobin. 3. Hb F (fetal): this is composed of two alpha and two gamma chains, it constitute 2% of total hemoglobin.
Basic types of hemoglobinopathy
The umbrella term "hemoglobinopathy" includes all genetic hemoglobin disorders. These are divided into two main groups. Both are caused by mutations and/or deletions in the α-or β-globin genes of hemoglobin.
 Thalassemia syndromes: These are autosomal recessive conditions resulting from the decreased or absent synthesis of globin chains. Alpha and beta thalassemia are the result of deficient or absent synthesis of α and β chains, respectively. Hemoglobin structure in these cases is normal.  Abnormal hemoglobins (structural hemoglobin variants): This group of autosomal dominant inherited hemoglobin disorders is caused by structural defects in heamoglobin synthesis resulting from an altered amino acid sequence in the α-or β-chains.
The most common types of hemoglobinopathies enrolled in Iraqi Premarital Counseling are discussed below.
I. Beta-thalassemias
Beta thalassemia (β-thal) syndromes are the result of insufficient (β+) or absent (β ) production of β-globin chains. Their molecular causes are β-globin gene mutations. Β-thalassemia is prevalent in populations in the Mediterranean, Middle East (including Iraq), Transcaucasia, Central Asia, Indian subcontinent, and Far East. It is also common in populations of African heritage. Hematological changes become manifest from between the ages of three months and six months onwards.
Genetic issues:
 Risk of being born with thalassemia and the severity of disease is dependent on the genetic composition of parents.  The gene for ß-thalassemia is autosomal recessive. However, a person with even one of these genes (heterozygous, carrier state) will have some hemoglobin changes, although these changes are often minor.  The transmission of defective gene and risk of being affected are outlined as:
 One parent with thalassemia minor (heterozygous) and the other is normal -50% chance of each child having thalassemia minor and 50% to be normal.  Both parents with thalassemia minor (heterozygous) -25% chance of each child having thalassemia major (homozygous), and 50% chance of each child also having thalassemia minor and only 25% chance that the child will not have some form of thalassemia. Note: There is certain type of thalassemia called thalassemia intermedia in which the clinical severity of the disease is somewhere between the mild symptoms of the β thalassemia trait and the severe manifestations of β thalassemia major. Thalassemia intermedia is inherited and may result from a wide variety of genotypes. Certain homozygous β thalassemia alleles have produced this condition. Additionally several forms of combined heterozygous thalassemia can also result in a clinical course consistent with thalassemia intermedia.
Clinical picture of ß-thalassemia
Laboratory Diagnosis of Thalassemia:
 MCV and MCH decreased -RBC indices are decreased, even in thalassemia minorThis is the first screening evidence of possible thalassemia (or other form of anemia).  Mild to severe anemia (depending on severity of thalassemia):
 HbA2 increased to >3.5%  HbF increased, sometimes to >90%  Peripheral blood smear shows abnormal RBC -microcytic, tear-drop shapes, and target cells.  Serum iron and ferritin are usually increased.  May have increased bilirubin, and abnormal liver function studies.
Treatment Options for Beta -Thalassemia
I. For Thalassemia Minor:
 Usually no treatment required.  May need occasional transfusion during times of physiologic stress.  Supplementation with folic acid often recommended.
II. For Thalassemia Major:
 Most patients require periodic transfusion to maintain adequate functioning hemoglobin and suppress increased erythropoesis.  With transfusions and maintenance of Hb. Level at 10-11 mg/dl. complications such as hypersplenism, fractures, infections, and orthopedic complications are less common.  Periodic transfusions lead to further iron overload, and need for iron chelation therapy with deferoxamine.  Should supplement with folic acid because of increased erythropoesis (production of RBC).  Radical treatments include bone marrow transplantation, or experimental gene therapy.
 Early management of complications.
Prevention strategies
 The only prevention of thalassemia major is to prevent passing down the genes to a child.  Primary strategy in Middle East is counseling of couple when both male and female found to be heterozygous thalassemia carriers.  In some countries, prenatal diagnosis can be made on fetus of two thalassemia carriers (small sample of fetal blood, or genetic analysis) to determine if fetus is affected.
Premarital Screening for thalassemia:
 All couples to be married will need certificate of probable thalassemia status.
 Both man and woman should be screened; although only one can be screened, and if positive, then request screening of second.  Screening test -RBC cell size and heamoglobin concentration (MCV and MCH) -should be greater than 80 and 27, respectively  If both RBC indices for one member of couple are normal (even if second member has abnormal low results), certificate can be given.  If at least one of RBC indices on BOTH members of couple has abnormal low value, BOTH patients referred for hemoglobin electrophoresis (or HPLC) as definitive test.  Other findings, such as blood smear findings, Hb level, iron or ferritin levels…etc, can provide additional information, but not as accurate as hemoglobin electrophoresis. 
Explanation of Results of Screening and Confirmatory Tests
II. Sickle Cell Disorder
The term "sickle-cell disorder" includes all manifestations of abnormal heamoglonin S levels (proportion of HbS >50%). These include spectrum ranging from homozygous sickle-cell disease (HbSS) through mixed heterozygous hemoglobinopathies (HbS/β-thalassemia, HbSC disease, and other combinations) to purely heterozygous sickle cell trait (HbSA). Sickle cell disease is most common in people living in or originating from sub-Saharan Africa. The disorder also affects people of Mediterranean, Caribbean, Middle-Eastern (including Iraq), and Asian origin.
Genetic issues:
 Sickle cell disease is inherited in an autosomal recessive manner.  If both parents are carriers of beta-globin (HBB) mutation, each offspring has at conception a 25% chance of being affected with the disease, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.  If one parent is homozygous and the other parent is heterozygous for an HBB mutation, each offspring has a 50% chance of being affected and a 50% chance of being an asymptomatic carrier.  If both parents are homozygous, all offspring will be affected.
Clinical picture of sickle cell disorder
 Sickle cell trait (heterozygous -carrier state)
 These individuals do not express symptoms of sickle cell disease  Individuals normally do not have anemia, except in the cases of mixed heterozygous hemoglobinopathies (e.g. HbS/β-thalassemia, HbSC disease, and other combinations).
 Although, Heterozygotes (carriers) are generally asymptomatic, but they may develop complications under extremes of physical exertion, dehydration, and/or altitude.
 Sickle cell disease (homozygous -disease state)
 Most individuals with sickle cell disease are healthy at birth and become symptomatic later on, after fetal hemoglobin (Hb F) levels decrease and hemoglobin S (Hb S) levels increase.  The severity of disease manifestations varies from severe to minimal, even in individuals with the same HBB mutation status.  The main causes of death are infection, acute chest syndrome, pulmonary artery hypertension, and cerebrovascular events.  If untreated, patients often have the following symptoms:
o Vaso-occlusive events result in tissue ischemia leading to acute and chronic pain as well as organ damage that can affect any organ in the body, including the bones, lungs, liver, kidneys, brain, eyes, and joints. o Dactylitis (pain and/or swelling of the hands or feet) in infants and young children is often the earliest manifestation of sickle cell disease.
o In children the spleen can become engorged with blood cells in a "splenic sequestration crisis." The spleen is also particularly subject to infarction and the majority of individuals with SCD are functionally asplenic in early childhood, increasing their risk for certain types of bacterial infections. o Chronic hemolysis results in varying degrees of anemia, jaundice, cholelithiasis, and delayed growth and sexual maturation. Individuals with the highest rates of hemolysis are predisposed to pulmonary artery hypertension, priapism, and leg ulcers but are relatively protected from vaso-occlusive pain.
Laboratory Diagnosis of Sickle Cell Disease:
 The presence of significant quantities of Hb S by high-performance liquid chromatography (HPLC), isoelectric focusing, or (less commonly) cellulose acetate or citrate agar electrophoresis  The lack of a normal β-globin gene on Molecular Genetic Testing.  Peripheral blood smear shows Sickle cells, nucleated red blood cells, and target cells may be seen.  MCV and HbA2 may be normal or reduced depending on specific genotype of disorder.
Treatment for Sickle Cell Disorder:
I. For Sickle Cell Trait:
 People with sickle cell trait can live full lives and enjoy most of the activities that other people do.  There are things that those people can do to stay as healthy as possible. Below are a few examples:  Get regular checkups. Regular health checkups with a primary care doctor can help prevent some serious problems.  Prevent infections. Common illnesses, like the flu, can quickly become dangerous for a child with sickle cell disease. The best defense is to take simple steps to help prevent infections.  Learn healthy habits. People with sickle cell trait should drink 8 to 10 glasses of water every day and eat healthy food. They also should try not to get too hot, too cold, or too tired.
II. For Sickle Disease:
 The mainstay is good hydration and avoidance of climate extremes, extreme fatigue, and activities leading to inflammation.  Hydroxyurea can decrease the frequency and severity of vaso-occlusive processes, reduce transfusion needs, and increase life span.  Chronic red blood cell transfusion is indicated in children with either a history of or risk factors for stroke and other specific complications, such as pulmonary hypertension and chronic renal failure.  Aggressive education on the management of fevers; prophylactic antibiotics, including penicillin in children; up-to-date immunizations; and iron chelation therapy for those with iron overload.  Early management of complications.
 Periodic monitoring investigation and follow-up examination
Prevention strategies
 As for thalassemia, the only way for prevention of sickle cell disease is to prevent passing down the genes to a child.  It is appropriate to provide counseling of couple when both male and female found to be heterozygous sickle cell carriers.  In some countries, Pre-implantation genetic diagnosis (PGD) may be available for families in which the disease-causing mutations have been identified.
Premarital Screening and counseling for sickle cell disorder:
 Routine screening for sickle cell disorder is not currently available in Iraq. However, this action can be offered to couple if any member of them is at high risk of being carrier (Table 4 ).  Those partners should be referred to health facility where appropriate investigations and counseling for sickle cell disorder are available.  Carrier detection for HBB mutations involving abnormal hemoglobin (e.g. sickling disorder) is most commonly accomplished by HPLC or hemoglobin electrophoresis. Note: It must be kept in mind that non-sickle β-globin disorders (e.g., β-thalassemia) can interact with the SCD-causing mutation leading to clinically significant disease. For example, if one parent has sickle cell trait and the other has β-thalassemia trait, it would be correct to state that, although one parent is not a sickle cell carrier, there is still a 25% chance that each pregnancy would have a significant hemoglobinopathy. Therefore, partners of individuals who are known to carry sickle cell trait should be offered a thalassemia screening panel that includes hemoglobin electrophoresis or HPLC to screen for carrier status for sickle cell trait and other β-globin disorders.
Box 4: Indications for Sickle Cell Testing in Premarital Counseling
Note: Premarital screening for other variants of structural heamoglobin abnormality (e.g. HbC, and HbE) is not performed routinely during premarital counseling.
Chapter 4: Premarital Guidelines for Sexually Transmitted Diseases
Premarital Counseling visits represent a good opportunity for detection and treatment of sexually transmitted diseases, as well as prevention of their transmission to the partner. It provides also the time for giving the advices and instructions of their risks, modes of transmission, and ways of avoidance and protection from them.
I. Hepatitis B
Hepatitis B is caused by infection with the hepatitis B virus (HBV). The incubation period from the time of exposure to onset of symptoms is 6 weeks to 6 months. HBV is more infectious and relatively more stable in the environment than other blood borne pathogens like HCV and HIV. Viral hepatitis is endemic in Iraq. The prevalence of HBsAg is 2-3% in the normal population. Both couples should do HBsAg as a routine giving that positive test will pick up 99%of cases, in addition to being also cheap and easy test. hepatitis B immune globulin (HBIG) and hepatitis B vaccine.  HBIG provides temporary (i.e. 3-6 months) protection from HBV infection and is typically used as PEP (post-exposure prophylaxis) either as an adjunct to hepatitis B vaccination in previously unvaccinated persons or alone in persons who have not responded to vaccination.  Hepatitis B vaccine provides protection from HBV infection when used for both pre-exposure vaccination and PEP.
Explanation of results of HBsAg test
Counseling:
 Partner notification is mandatory.  Vaccination is advised for the partner (three doses at 0 -1 -6 months).  Do (Anti HBsAb) within 1-4 weeks from the third dose to check immunity 
Follow-up:
The following investigations should be requested for the patient every 6 months: 1. Hepatitis B profile (HBsAg, Anti HBc(IgM), HBeAg, AntiHBeAb) . Liver function test (LFT), prothrombin time(PT), and complete blood count (CBC). . Liver Ultrasound
The result of these investigations will determine the patient status:
 
II. Syphilis
Syphilis is a systemic disease caused by Treponema pallidum. On the basis of clinical findings, the disease has been divided into a series of overlapping stages, which are used to help guide treatment and follow-up.
Stages of Syphilis:
. Primary stage: there is ulcer or chancre at the infection site. . Secondary stage: its manifestations include, but are not limited to, skin rash, mucocutaneous lesions, and lymphadenopathy. . The latent stage: this begins when primary and secondary symptoms disappear.
Latent syphilis acquired within the preceding year is referred to as early latent syphilis; other cases of latent syphilis are late latent syphilis. . Tertiary stage: symptoms include difficulty coordinating muscle movements, paralysis, numbness, gradual blindness, and dementia. The disease damages the internal organs, including the brain, nerves, eyes, heart, blood vessels, liver, bones, and joints. This damage can result in death.
